Introduction
The efficacy of vitamin D for migraine remains controversial. We conduct a systematic review and meta-analysis to explore the influence of vitamin D versus placebo on treatment in migraine patients.
Methods
We search PubMed, EMbase, Web of Science, EBSCO, and Cochrane library databases through April 2020 for randomized controlled trials assessing the effect of vitamin D versus placebo on treatment efficacy in migraine patients. This meta-analysis is performed using the random-effect model.
Results
Five randomized controlled trials are included in the meta-analysis. Overall, compared with control group in migraine patients, vitamin D treatment is associated with substantially reduced number of headache days (standard mean difference [SMD], −0.53; 95% confidence interval [CI], −0.83 to −0.23; P = 0.0006), frequency of headache attacks (SMD, −1.09; 95% CI, −1.86 to −0.32; P = 0.006), headache severity (SMD, −0.55; 95% CI, −0.91 to −0.19; P = 0.0003), and Migraine Disability Assessment score (SMD, −0.76; 95% CI, −1.11 to −0.40; P < 0.0001).
Conclusions
Vitamin D treatment is effective to alleviate migraine.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.